Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK
Lilly is racing to file orforglipron for type 2 diabetes in 2026 while advancing retatrutide toward what could be the most efficacious obesity therapy yet studied
These results may be reflective of a suppressant effect of liraglutide on weight and HbA1c in the treatment arm
Semaglutide can result in delayed gastric emptying, which reduces the rate at which food moves from the stomach to the small intestine
One thing outsiders miss about Tulsa: the city has been investing heavily in attracting remote workers through the Tulsa Remote program, which means the patient base now includes tech transplants from the coasts alongside longtime Oklahomans